In the late 2000s and early 2010s, neurogeneticist Vivek Kumar, then a postdoctoral researcher at the University of Texas Southwestern Medical Center, screened thousands of randomly mutagenized mice.

This blog post concludes a five-part series I ran this week on some of the keys intersecting AI and compliance. Yesterday, I wrote that businesses must proactively address the potential for bias at ...

A KAIST research team led by Professor Keon Jae Lee has proposed an innovative theoretical framework and research strategies for AI-based wearable blood pressure sensors, paving the way for continuous ...

PatentVest has published a report titled "Continuous Glucose Monitoring (CGM): An Evolving Innovation Landscape," which examines the rapidly growing CGM market, crucial for managing diabetes, a ...

Innovating to overcome existing challenges Monitoring biomarkers -- chemicals found in blood or other body fluids that capture what is happening in a cell or an organism at a given moment -- ...

In recent years, diabetes management has undergone a remarkable transformation with the rise in continuous glucose monitors (CGMs). These devices present patients with an easier way to maintain ...